CLEVELAND BIOLABS INC Investment Agreements
4 Contracts & Agreements
- Director Designation Agreement, dated as of August 10, 2018, among Genome Protection, Inc., Everon Biosciences, Inc., Cleveland BioLabs, Inc. and Norma Investments Limited (Filed With SEC on August 14, 2018)
- Simple Agreement for Future Equity, dated as of August 10, 2018, among Genome Protection, Inc., Norma Investments Limited, Cleveland BioLabs, Inc. and Everon Biosciences, Inc (Filed With SEC on August 14, 2018)
- AMENDMENT NO. 1 TO INVESTMENT AGREEMENT OF PANACELA LABS, INC. (Filed With SEC on March 17, 2014)
- INVESTMENT AGREEMENT (Filed With SEC on November 9, 2011)
